Q1 FY27 snapshot
Announcement Date10-Aug-26
Revenue (Top Line)₹ 683 Cr
Net Profit (Bottom Line)₹ 37.9 Cr
Earnings Per Share (EPS)₹15.17
Expenses₹ 634 Cr
Net profit margin (calculated)5.5%
AstraZeneca Pharma India Ltd. (ASTRAZEN) Quarterly Results: Q1 FY27
Quick answer: AstraZeneca Pharma India Ltd. (NSE: ASTRAZEN) reported Q1 FY27 revenue of ₹ 683 Cr and net profit of ₹ 37.9 Cr, with earnings per share (EPS) of ₹15.17, announced on 10-Aug-26.
That works out to a net profit margin of about 5.5% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read AstraZeneca Pharma India Ltd.'s Q1 FY27 results
Revenue of ₹ 683 Cr is what AstraZeneca Pharma India Ltd. earned before costs. Net profit of ₹ 37.9 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 5.5%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
AstraZeneca Pharma India Ltd. results FAQs
What were AstraZeneca Pharma India Ltd.'s Q1 FY27 results?
AstraZeneca Pharma India Ltd. (NSE: ASTRAZEN) reported Q1 FY27 revenue of ₹ 683 Cr and net profit of ₹ 37.9 Cr, with earnings per share (EPS) of ₹15.17, announced on 10-Aug-26.
What is AstraZeneca Pharma India Ltd.'s EPS for Q1 FY27?
AstraZeneca Pharma India Ltd.'s earnings per share for Q1 FY27 was ₹15.17. EPS is net profit divided by the number of outstanding shares.
When did AstraZeneca Pharma India Ltd. announce its Q1 FY27 results?
AstraZeneca Pharma India Ltd. announced its Q1 FY27 results on 10-Aug-26.
What is AstraZeneca Pharma India Ltd.'s net profit margin?
On the reported figures, AstraZeneca Pharma India Ltd.'s Q1 FY27 net profit margin is about 5.5% (net profit ÷ revenue).